Department of Cardiology, The Second Hospital of Shandong University, Jinan, China.
Division of Life Sciences and Medicine, Department of Cardiology, the First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.
Am J Physiol Cell Physiol. 2024 Jun 1;326(6):C1611-C1624. doi: 10.1152/ajpcell.00606.2023. Epub 2024 Apr 22.
The influence of SGLT-1 on perivascular preadipocytes (PVPACs) and vascular remodeling is not well understood. This study aimed to elucidate the role and mechanism of SGLT-1-mediated PVPACs bioactivity. PVPACs were cultured in vitro and applied ex vivo to the carotid arteries of mice using a lentivirus-based thermosensitive in situ gel (TISG). The groups were treated with Lv-SGLT1 (lentiviral vector, overexpression), Lv-siSGLT1 (RNA interference, knockdown), or specific signaling pathway inhibitors. Assays were conducted to assess changes in cell proliferation, apoptosis, glucose uptake, adipogenic differentiation, and vascular remodeling in the PVPACs. Protein expression was analyzed by Western blotting, immunocytochemistry, and/or immunohistochemistry. The methyl thiazolyl tetrazolium (MTT) assay and Hoechst 33342 staining indicated that SGLT-1 overexpression significantly promoted PVPACs proliferation and inhibited apoptosis in vitro. Conversely, SGLT-1 knockdown exerted the opposite effect. Oil Red O staining revealed that SGLT-1 overexpression facilitated adipogenic differentiation, while its inhibition mitigated these effects. H-labeled glucose uptake experiments demonstrated that SGLT-1 overexpression enhanced glucose uptake by PVPACs, whereas RNA interference-mediated SGLT-1 inhibition had no significant effect on glucose uptake. Moreover, RT-qPCR, Western blotting, and immunofluorescence analyses revealed that SGLT-1 overexpression upregulated FABP4 and VEGF-A levels and activated the Akt/mTOR/p70S6K signaling pathway, whereas SGLT-1 knockdown produced the opposite effects. In vivo studies corroborated these findings and indicated that SGLT-1 overexpression facilitated carotid artery remodeling. Our study demonstrates that SGLT-1 activation of the Akt/mTOR/p70S6K signaling pathway promotes PVPACs proliferation, adipogenesis, glucose uptake, glucolipid metabolism, and vascular remodeling. SGLT-1 is expressed in PVPACs and can affect preadipocyte glucolipid metabolism and vascular remodeling. SGLT-1 promotes the biofunctions of PVPACs mediated by Akt/mTOR/p70S6K signaling pathway. Compared with caudal vein or intraperitoneal injection, the external application of lentivirus-based thermal gel around the carotid artery is an innovative attempt at vascular remodeling model, it may effectively avoid the transfection of lentiviral vector into the whole body of mice and the adverse effect on experimental results.
SGLT-1 对血管周围前脂肪细胞 (PVPACs) 和血管重塑的影响尚不清楚。本研究旨在阐明 SGLT-1 介导的 PVPACs 生物活性的作用和机制。将 PVPACs 在体外培养,并使用基于慢病毒的热敏原位凝胶 (TISG) 在体外应用于小鼠颈动脉。各组用 Lv-SGLT1(慢病毒载体,过表达)、Lv-siSGLT1(RNA 干扰,敲低)或特定信号通路抑制剂处理。通过 MTT 法和 Hoechst 33342 染色检测 PVPACs 中细胞增殖、凋亡、葡萄糖摄取、脂肪生成分化和血管重塑的变化。通过 Western blot、免疫细胞化学和/或免疫组织化学分析蛋白质表达。噻唑蓝(MTT)法和 Hoechst 33342 染色表明 SGLT-1 过表达可显著促进 PVPACs 的增殖并抑制体外细胞凋亡。相反,SGLT-1 敲低则产生相反的效果。油红 O 染色显示 SGLT-1 过表达促进脂肪生成分化,而 SGLT-1 抑制则减轻了这些作用。H-标记的葡萄糖摄取实验表明 SGLT-1 过表达增强了 PVPACs 的葡萄糖摄取,而 RNA 干扰介导的 SGLT-1 抑制对葡萄糖摄取没有显著影响。此外,RT-qPCR、Western blot 和免疫荧光分析表明,SGLT-1 过表达上调了 FABP4 和 VEGF-A 水平并激活了 Akt/mTOR/p70S6K 信号通路,而 SGLT-1 敲低则产生相反的效果。体内研究证实了这些发现,并表明 SGLT-1 过表达促进了颈动脉重塑。我们的研究表明,SGLT-1 通过激活 Akt/mTOR/p70S6K 信号通路促进 PVPACs 的增殖、脂肪生成、葡萄糖摄取、糖脂代谢和血管重塑。SGLT-1 在 PVPACs 中表达,并可影响前脂肪细胞的糖脂代谢和血管重塑。SGLT-1 促进 Akt/mTOR/p70S6K 信号通路介导的 PVPACs 生物功能。与尾静脉或腹腔注射相比,将基于慢病毒的热凝胶应用于颈动脉周围是一种血管重塑模型的创新尝试,它可能有效地避免慢病毒载体转染到小鼠全身和对实验结果产生不利影响。